Company
Pipeline
Science
logo
Media
Careers
Contact

Investors

Latest News

October 2, 2019

Graybug Vision Initiates Phase 2b (ALTISSIMO) Clinical Trial of GB-102 in Patients with Wet Age-Related Macular Degeneration

September 18, 2019

Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion

August 20, 2019

Graybug Vision Secures $80 million of Additional Funding to Advance its Potentially Transformative Retina and Glaucoma Clinical Programs

To reduce the burden of treatment for patients with vision-threatening diseases through the development of injectable therapeutics that enable less frequent intervention and improve medical delivery for the physician.

Graybug Vision, Inc.
275 Shoreline Drive
Suite 450
Redwood City, CA 94065

info@graybug.com

Register for News Updates:

Subscribe to our company news email list and receive Graybug news as it is released. Your privacy is important, and your email address will be used only for this news distribution list.

Navigation

Home
Company
Pipeline
Science
Media
Careers
Contact

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok